business

GSK Profit Beats Estimates on HIV, Cancer Medicines

Bloomberg Markets · Apr 29, 2026, 6:12 AM · Also reported by 2 other sources

GSK Plc’s profit was higher than analysts expected in the first quarter, helped by the drugmaker’s specialty medicines for HIV, cancer and immune diseases.

Read full story on Bloomberg Markets → More top stories

Also covered by

Bloomberg Tech Apple Sales Forecast Beats Estimates CNBC Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

GSK Profit Beats Estimates on HIV, Cancer Medicines

Also covered by

More in business